	Sep 2026	Jun 2026	Sep 2025	QoQ%	YoY%
Revenue/Sales	629.84	610.36	534.04	3.19%	17.94%
EBITDA	256.51	247.03	219.54	3.84%	16.84%
Op. profit margin(%)	35.44	34.98	35.42	1.33%	0.05%
Net Profit	178.10	176.91	154.45	0.67%	15.31%
EPS	23.44	23.27	20.32	0.73%	15.35%

* Consolidated data

Detailed Results

Caplin Point Laboratories Ltd.

12 Nov 2026, 01:08PM

2388.70

0.10%

Board Meeting

Caplin Point Laboratories Ltd - 524742 - Board Meeting Outcome for Meeting Held On November 12, …

BSE India

Board Meeting Outcome for Meeting Held on November 12, 2026

pdf

Caplin Point Laboratories Ltd.

02 Nov 2026

2388.70

0.10%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Analyst / investor Call for the quarter and half ended September 30, 2026

pdf

Caplin Point Laboratories Ltd.

02 Nov 2026

2388.70

0.10%

Board Meeting

Caplin Point Laboratories Ltd - 524742 - Board Meeting Intimation for Considering And Approving, Inter-Alia, The …

BSE India

Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the unaudited financial results of the Company for the quarter and half-year ended September 30, 2026.

pdf

Caplin Point Laboratories Ltd.

07 Oct 2026

2388.70

0.10%

Company Update

Caplin Point Laboratories Ltd - 524742 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 for the quarter and half year ended September 30, 2026.

pdf